Diphtheria tetanus toxoid and pertussis first-dose (DTP1) in Slovakia
Slovakia: Diphtheria tetanus toxoid and pertussis first-dose (DTP1) was 96.0% in 2025. ▬ Flat
Latest (2025)
96.0%
Change on year
unchanged
World rank
85th
of 194 countries
All-time high
99.0%
in 2000
All-time low
96.0%
in 2023
Years of data
26
2000–2025
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) in Slovakia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Slovakia recorded 96.0% for diphtheria tetanus toxoid and pertussis first-dose (dtp1) in 2025. That is the lowest value across all 26 years on record.
That represents a change of down 3.0% over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis first-dose (dtp1) in Slovakia peaked at 99.0% in 2000 and was at its lowest, 96.0%, in 2023.
That places Slovakia 85th out of 194 countries with data for 2025, putting it in the middle of the range.
Diphtheria tetanus toxoid and pertussis first-dose (DTP1) in Slovakia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 99.0% | — |
| 2001 | 99.0% | +0.0% |
| 2002 | 99.0% | +0.0% |
| 2003 | 99.0% | +0.0% |
| 2004 | 99.0% | +0.0% |
| 2005 | 99.0% | +0.0% |
| 2006 | 99.0% | +0.0% |
| 2007 | 99.0% | +0.0% |
| 2008 | 99.0% | +0.0% |
| 2009 | 99.0% | +0.0% |
| 2010 | 99.0% | +0.0% |
| 2011 | 99.0% | +0.0% |
| 2012 | 99.0% | +0.0% |
| 2013 | 99.0% | +0.0% |
| 2014 | 99.0% | +0.0% |
| 2015 | 99.0% | +0.0% |
| 2016 | 99.0% | +0.0% |
| 2017 | 99.0% | +0.0% |
| 2018 | 99.0% | +0.0% |
| 2019 | 99.0% | +0.0% |
| 2020 | 98.0% | -1.0% |
| 2021 | 97.0% | -1.0% |
| 2022 | 97.0% | +0.0% |
| 2023 | 96.0% | -1.0% |
| 2024 | 96.0% | +0.0% |
| 2025 | 96.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 99.0% | 99.0% | 99.0% | 10 |
| 2010s | 99.0% | 99.0% | 99.0% | 10 |
| 2020s | 96.7% | 96.0% | 98.0% | 6 |
Countries ranked near Slovakia
More health data for Slovakia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9332 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,433 deaths per 1,000 people (2090)
- Number of infants who die before age 1 28 deaths (2100)
- Population ages 60-64, female, annual growth rate 0.3055 % change on previous year (2025)
- Population ages 60-64, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, female, per capita 0.0328 units per person (2025)
- Population ages 60-64, male, annual growth rate 0.4767 % change on previous year (2025)
- Population ages 60-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 60-64, male, per capita 0.03 units per person (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis first-dose (dtp1) in Slovakia?
- Diphtheria tetanus toxoid and pertussis first-dose (dtp1) in Slovakia was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis first-dose (dtp1) recorded in Slovakia?
- The highest recorded value was 99.0% in 2000.
- What is the lowest diphtheria tetanus toxoid and pertussis first-dose (dtp1) recorded in Slovakia?
- The lowest recorded value was 96.0% in 2023.
- How does Slovakia rank for diphtheria tetanus toxoid and pertussis first-dose (dtp1)?
- Slovakia ranks 85th out of 194 countries with data for 2025.
- Is diphtheria tetanus toxoid and pertussis first-dose (dtp1) rising or falling in Slovakia?
- Over the last ten years it is down 3.0%. The long-run trend across the full record is flat.
- Where does this Slovakia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis first-dose (DTP1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).